X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-01-27 | CMPI | Krieg Arthur M | Chief Scientific Officer | P - Purchase | $13.05 | +1,701 | 938,562 | 0% | +$22,198 | ||||||
2021-01-19 | CMPI | Krieg Arthur M | Chief Scientific Officer | P - Purchase | $13.09 | +500 | 936,861 | 0% | +$6,545 | ||||||
2020-12-29 | CMPI | Krieg Arthur M | Chief Scientific Officer | P - Purchase | $14.16 | +443 | 936,361 | 0% | +$6,273 | ||||||
2020-12-22 | CMPI | Krieg Arthur M | Chief Scientific Officer | P - Purchase | $14.64 | +5,103 | 935,918 | +1% | +$74,708 | ||||||
| M | 2020-12-15 | CMPI | Krieg Arthur M | Chief Scientific Officer | P - Purchase | $14.62 | +4,847 | 930,815 | +1% | +$70,858 | |||||
| D | 2020-08-11 | CMPI | Novo Holdings A/s | 10% | P - Purchase | $15.00 | +500,000 | 2,170,100 | +30% | +$7,500,000 | |||||
| D | 2020-08-11 | CMPI | Powell Michael | Dir, 10% | P - Purchase | $15.00 | +133,333 | 3,606,707 | +4% | +$1,999,995 | |||||
| D | 2020-08-11 | CMPI | Venbio Global Strategic Fund II L.P. | 10% | P - Purchase | $15.00 | +200,000 | 3,673,374 | +6% | +$3,000,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |